Keyphrases
Heart Failure
94%
Cardiomyocytes
41%
Myocardial Infarction
33%
Left Ventricular Function
28%
Inflammation
26%
Cardiac Function
23%
Failing Heart
19%
Post-myocardial Infarction
19%
Ischemia-reperfusion Injury
17%
Pressure Overload
16%
Heart Failure with Preserved Ejection Fraction (HFpEF)
16%
Ischemic Heart Failure
15%
Cardiac Remodeling
14%
Apoptosis
14%
Confidence Interval
14%
Cardiomyopathy
14%
Left Ventricular Remodeling
14%
Acrolein
14%
Cardiovascular Disease
13%
Myocytes
13%
Myocardium
13%
Left Ventricular Dysfunction
13%
Interleukin-18 (IL-18)
12%
Cell Culture Model
12%
Tumor Necrosis Factor-α
12%
Cardiovascular Risk
12%
O-linked N-acetylglucosamine (O-GlcNAc)
12%
Adverse Cardiac Remodeling
11%
Oxidative Stress
11%
Aldehydes
11%
Estimated Glomerular Filtration Rate
11%
Nitric Oxide
11%
Cardioprotection
11%
Interleukin-1β
11%
Hazard Ratio
10%
Left Ventricle
10%
Cardiac Hypertrophy
10%
Inducible Nitric Oxide Synthase
10%
Medicare Beneficiaries
10%
Endothelial Cell Culture
10%
TNF Receptor 1 (TNFR1)
10%
Leukocytes
9%
Infarct Size
9%
Hypertrophy
9%
Angiotensin II (Ang II)
9%
Nuclear factor-B
9%
Gene Expression
9%
Reperfusion
8%
Cardiac Dysfunction
8%
Calves
8%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Heart Ventricle Remodeling
36%
Heart Infarction
35%
Inflammation
30%
Acrolein
13%
Cytokine
13%
Calcium Ion
13%
Infarction
13%
Tumor Necrosis Factor
13%
Myocardial Disease
13%
Heart Muscle Ischemia
11%
Transferase
10%
Cardiovascular Disease
10%
Fibrosis
10%
Messenger RNA
9%
Cerebrovascular Accident
9%
Nitric Oxide
9%
Angiotensin II
9%
Alternative Complement Pathway C3 C5 Convertase
9%
Nuclear Factor
9%
Aortic Constriction
9%
Adrenergic Receptor
8%
Tumor Necrosis Factor Receptor
8%
Wild Type Mouse
7%
Heart Ventricle Hypertrophy
7%
Interleukin 18
7%
Heart Failure with Preserved Ejection Fraction
7%
Heart Left Ventricle Failure
7%
Fatty Acid
7%
Heart Muscle Fibrosis
7%
Reactive Oxygen Metabolite
7%
All Cause Mortality
7%
Diseases
6%
Reperfusion Injury
6%
Cardiotoxicity
6%
Diabetic Cardiomyopathy
6%
Cardiovascular Mortality
6%
Atrial Fibrillation
6%
Clinical Trial
5%
Natriuretic Factor
5%
Diabetes Mellitus
5%
Systolic Heart Failure
5%
Ischemic Cardiomyopathy
5%
Receptor
5%
Protein Kinase B
5%
Congestive Cardiomyopathy
5%
Heart Failure with Reduced Ejection Fraction
5%
Synapsin I
5%
Glutathione
5%
Interleukin 1
5%
Medicine and Dentistry
Congestive Heart Failure
82%
Cardiac Muscle Cell
28%
Heart Ventricle Remodeling
26%
Hemodynamic
21%
Heart Function
19%
Cardiovascular Disease
16%
Cardiovascular System
15%
In Vitro
13%
Heart Muscle Ischemia
12%
Cell Culture
11%
Endothelial Cell
11%
Ventricular Assist Device
10%
Heart Failure with Preserved Ejection Fraction
10%
Programmed Cell Death
10%
Aortic Constriction
9%
Infarction
9%
Fibrosis
9%
Myocardial Infarction
9%
Coronary Artery Disease
8%
Myocardium
8%
Ventricular Hypertrophy
8%
Oxidative Stress
8%
Tumor Necrosis Factor Receptor
8%
Counterpulsation
7%
Left Ventricle
7%
Cardiovascular Mortality
7%
Macrophage
7%
Cardiac Fibrosis
7%
Leukocyte
7%
Nuclear Factor
7%
Echocardiography
7%
Immunity
6%
Reactive Oxygen Species
6%
Alternative Complement Pathway C3 C5 Convertase
6%
Left Ventricular Assist Device
6%
Tumor Necrosis Factor
6%
Diseases
6%
Upregulation
6%
Heart Left Ventricle Failure
6%
Meta-Analysis
5%
Myocardial Disease
5%
Adrenergic Receptor
5%
Cytokine
5%
Ischemic Cardiomyopathy
5%
Clinical Trial
5%
Amino Terminal Sequence
5%
Coronary Circulation
5%
Cardiovascular Risk
5%
Atrial Fibrillation
5%
Diabetes Mellitus
5%